http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2650175-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b5050f8a78737ea730347d5e3d039fd0 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-635 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-606 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-606 |
| filingDate | 2016-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08f34ee10889ecbd343bea282f4feabe |
| publicationDate | 2018-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2650175-A1 |
| titleOfInvention | Treatment of neurodegenerative diseases |
| abstract | Treatment of neurodegenerative diseases. # Use of a composition comprising an aminosalicylate in the preparation of a medicament for the relief, improvement, prevention and / or treatment of diseases or disorders related to an aggregating protein, and specifically Parkinson's disease. |
| priorityDate | 2016-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 187.